Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.440
+0.030 (1.24%)
At close: Mar 25, 2026, 4:00 PM EDT
2.480
+0.040 (1.64%)
After-hours: Mar 25, 2026, 6:10 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $313.88 million as of March 25, 2026. Its market cap has decreased by -51.76% in one year.
Market Cap
313.88M
Enterprise Value
299.45M
1-Year Change
-51.76%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $313.88M, a decrease of -74.61%. That is a compound annual growth rate of -17.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 310.02M | -52.84% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 480.86M |
| Kamada | 477.93M |
| Emergent BioSolutions | 414.72M |
| Akebia Therapeutics | 379.05M |
| Canopy Growth | 363.66M |
| SIGA Technologies | 348.55M |
| Evolus | 300.58M |
| Anika Therapeutics | 191.43M |